{"text": "with tropics 02 expectations rock bottom could there be an upside surprise tomorrow asco22 gild"}
{"text": "yescarta car t cell therapy demonstrates consistent survival outcomes and safety in real world setting regardless of race a gild"}
{"text": "commented on gild gilead s yescarta shows consistent real world survival outcomes regardless of race"}
{"text": "commented on gild gilead sciences inc gild management presents at bernstein 38th annual strategic decisions conference transcript"}
{"text": "full disclosure i have a mid sized long term trading position in gild"}
{"text": "the market isn t giving gild s oncology pipeline any credit imo 11 oncology programs in ph3 w another 14 ph2 programs they also have hiv hbv hdv inflammatory amp fibrotic disease amp cell therapy programs great chance gild outperform bigly over the next few years imo"}
